Clinical Trial Update: MSC in Patients With Xerostomia Post XRT in Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating mesenchymal stem cell therapy for xerostomia after radiotherapy in head and neck cancer. Results have been posted, and the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Xerostomia

Drugs mentioned

• Mesenchymal stem cell therapy (mesenchymal stem cells)

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Xerostomia Following Radiotherapy | Phase 1 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2024-02-23